½ÃÀ庸°í¼­
»óǰÄÚµå
1461243

¼¼°èÀÇ Å¬·Î·ÎÀÚÀÏ·¹³î ½ÃÀå Æò°¡ : Çüź°, ¿ëµµº°, ¼øµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2017-2031³â)

Chloroxylenol Market Assessment, By Form, By Application, By Purity, By End-use, By Region, Opportunities and Forecast, 2017-2031F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Xcel - Markets and Data | ÆäÀÌÁö Á¤º¸: ¿µ¹® 230 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°è Ŭ·Î·ÎÀÚÀÏ·¹³î ½ÃÀå ±Ô¸ð´Â 2023³â 1¾ï 5,130¸¸ ´Þ·¯¿¡¼­ 2031³â 1¾ï 9,923¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 3.5% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÆÛ½º³ÎÄɾî Á¦Ç° ¹× È­ÀåǰÀÇ »ç¿ë Áõ°¡, Á¦¾à ÀÀ¿ë ºÐ¾ßÀÇ ¼ºÀå µîÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÆÛ½º³ÎÄɾî Á¦Ç° ¹× È­ÀåǰÀÇ »ç¿ëÀÌ Áõ°¡Çϸ鼭 ¼¼°è Ŭ·Î·ÎÀÚÀÏ·¹³î ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÆÛ½º³ÎÄɾî Á¦Ç° ¹× È­Àåǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿Ü¸ð¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ÁÖ¿ä È­Àåǰ Á¦Á¶¾÷üÀÇ ¸¶ÄÉÆÃ ¹× È«º¸ Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¼Ò¼È ¹Ìµð¾î ÄÁÅÙÃ÷ Á¦ÀÛÀÚÀÇ ¿µÇâ·ÂÀÌ Ä¿Áö¸é¼­ ¼ÒºñÀÚµéÀº È­Àåǰ ¹× ÆÛ½º³ÎÄɾî Á¦Ç°¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´õ¿í ´Ã¸®°í ÀÖÀ¸¸ç, ´Ù¾çÇÑ ÆÛ½º³ÎÄɾî Á¦Ç° ¹× È­Àåǰ¿¡ Ŭ·Î·ÎÀÚÀÏ·¹³îÀÌ »ç¿ëµÇ¸é¼­ ½ÃÀå È®ÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. The Personal Care Association¿¡ µû¸£¸é 2022³â À¯·´ È­Àåǰ ½ÃÀå ±Ô¸ð´Â ¼Ò¸ÅÆÇ¸Å°¡°Ý(RSP) ±âÁØ 950¾ï ´Þ·¯(880¾ï À¯·Î)¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ·Î·ÎÀÚÀÏ·¹³îÀº ´Ù¾çÇÑ È­Àåǰ ¹× ÆÛ½º³ÎÄɾî Á¦Ç°¿¡ Ç×±ÕÁ¦·Î »ç¿ëµÇ±â ¶§¹®¿¡ È­Àåǰ ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷ÀÇ ±Þ¼ÓÇÑ È®ÀåÀº Ŭ·Î·ÎÀÚÀÏ·¹³î¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

ÀÇ·á ºÐ¾ß¿¡¼­ Ŭ·Î·ÎÀÚÀÏ·¹³îÀÇ »ç¿ë È®´ëµµ ¼¼°è Ŭ·Î·ÎÀÚÀÏ·¹³î ½ÃÀå ±Ô¸ð¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. Ŭ·Î·ÎÀÚÀÏ·¹³îÀº Ç×±Õ ¹æºÎÁ¦·Î ÀÛ¿ëÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ¿¬°í ¹× Å©¸²°ú °°Àº ¿Ü¿ëÁ¦ÀÇ Á¦¾à ºÎÇüÁ¦·Î Àú³óµµ·Î »ç¿ëµË´Ï´Ù. Ŭ·Î·ÎÀÚÀÏ·¹³îÀº »óó¿Í ÇǺΠ¼Òµ¶¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ µ¶Á¡ ¼Òµ¶Á¦ÀÇ ÀϹÝÀûÀÎ ¼ººÐ Áß ÇϳªÀÔ´Ï´Ù. Ä¡·á ¿ëµµ·Î´Â °¨¿°µÈ ±Ù°ü ¹× ¿©µå¸§ Ä¡·á¸¦ À§ÇØ Å¬·Î·ÎÀÚÀÏ·¹³îÀ» ¿¬±¸Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ºÎ¹®ÀÇ Å¬·Î·ÎÀÚÀÏ·¹³î ¼ö¿ä Áõ°¡

Ŭ·Î·ÎÀÚÀÏ·¹³îÀº Ç×±ÕÁ¦·Î ÀÛ¿ëÇÏ¿© Âû°ú»ó, ÀÚ»ó, ¹°¸° »óó, º£ÀÎ »óó µîÀ» Ä¡·áÇÕ´Ï´Ù. ¼Õ ¼Òµ¶ ¼¼Á¤Á¦·Îµµ »ç¿ëµË´Ï´Ù. ±×¶÷À½¼º±Õ°ú Æ÷µµ»ó±¸±Õ¿¡´Â ¾àÇÏ°Ô ÀÛ¿ëÇÏ°í ±×¶÷¾ç¼º±Õ¿¡´Â È¿°úÀûÀÔ´Ï´Ù. ½´µµ¸ð³ª½º ¼Ó¿¡´Â ºÒȰ¼ºÀÔ´Ï´Ù. ±×¶÷À½¼º±Õ¿¡ ´ëÇÑ È°¼ºÀº ų·¹ÀÌÆ®Á¦ÀÎ ¿¡µ¥Åä»êÀ» ÷°¡ÇÏ¿© Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. Ŭ·Î·ÎÀÚÀÏ·¹³îÀÇ ²ú´ÂÁ¡Àº 246¡É, À¶Á¡Àº 115.5¡ÉÀÔ´Ï´Ù. ¿¡Å׸£, °íÁ¤À¯, Å׸£Ææ·ù¿¡ ¿ëÇØµÇ°í, ¹°¿¡ ¾ÆÁÖ ¾à°£ ¿ëÇØµÇ¸ç, ¿¡Åº¿Ã¿¡ Àß ³ì´Â´Ù. ¶ÇÇÑ ¼ö»êÈ­¾ËÄ®¸® ¼ö¿ë¾×¿¡µµ ½±°Ô ¿ëÇØµË´Ï´Ù.

Ŭ·Î¿Á½Ã·¹³îÀº ºÐÀÚ·® 156.61g/mol, ºÐÀÚ½Ä C8H9ClO·Î ¼ö¼ú±â±¸¿Í ÇǺÎÀÇ ¼Òµ¶ ¹× ¹æºÎÁ¦·Î »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î, Lancet Commission on Global Surgery¿¡ µû¸£¸é Àεµ¿¡¼­´Â Àα¸ 10¸¸ ¸í´ç ¿¬°£ 3,646°ÇÀÇ ¼ö¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ Áß ¾È°ú ¼ö¼úÀÌ 13%, »êºÎÀΰú ¼ö¼úÀÌ 20%, ÀÏ¹Ý ¼ö¼úÀÌ 26%¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀÌó·³ ´Ù¾çÇÑ ¸¸¼ºÁúȯÀ» Ä¡·áÇÏ´Â ´Ù¾çÇÑ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Á¦Ç° ¼ö¿ä¸¦ °­È­ÇÏ¿© ½ÃÀå È®´ë¸¦ º¸¿ÏÇϰí ÀÖ½À´Ï´Ù.

Á¦¾à ºÎ¹® ¼ö¿ä Áõ°¡·Î ¼¼°è Ŭ·Î·ÎÀÚÀÏ·¹³î ½ÃÀå ¼ö¿ä ÃËÁø

Ŭ·Î ·Ï½Ã ·¹³îÀº ´Ù¾çÇÑ Á¦¾à ÇöÀå°ú º´¿ø¿¡¼­ ¼Òµ¶Á¦·Î »ç¿ëµË´Ï´Ù. ±×°ÍÀº °í¼Ó ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ ºÐ¸® Àü¿¡ ºÒ¼Ò À¯µµÃ¼ È­ÀÇ µµ¿òÀ¸·Î ´Ù¾çÇÑ Á¦¾à Á¦Á¦ÀÇ ºÐ¼® ¹°ÁúÀ» ÃøÁ¤ÇÏ´Â Á¦¾à Ç¥ÁØ ¹°Áú·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Ŭ·Î·ÎÀÚÀÏ·¹³îÀº È­ÇÐÀû ¾ÈÁ¤¼ºÀÌ ¿ì¼öÇÏ°í ¹°¿¡ ´ëÇÑ ¿ëÇØµµ°¡ 0.03%À̸ç, ±¤¹üÀ§ÇÑ ½ºÆåÆ®·³À» °¡Áø È¿À²ÀûÀÌ°í µ¶¼ºÀÌ ³·Àº Ç×±ÕÁ¦ÀÔ´Ï´Ù. Ŭ·Î·ÎÀÚÀÏ·¹³îÀº Àú³óµµ¿¡¼­ ±¤¹üÀ§ÇÑ ¹ÚÅ׸®¾Æ¸¦ »ì±ÕÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ÀÌ È­ÇÕ¹°ÀÇ Ç×±Õ ÀÛ¿ëÀº ¼¼Æ÷¸· ÀüÀ§¸¦ ÆÄ±«ÇÏ¿© ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼­ À§ÀÇ ÀåÁ¡À¸·Î ÀÎÇØ Á¦¾à ºÎ¹®¿¡¼­ Ŭ·Î·ÎÀÚÀÏ·¹³îÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è Ŭ·Î·ÎÀÚÀÏ·¹³î ½ÃÀåÀÇ ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è Ŭ·Î·ÎÀÚÀÏ·¹³î ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, ½ÃÀå ¿ªÇÐ, ÁÖ¿ä ±â¾÷ ÇöȲ ¹× Àü¸Á µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÇÁ·ÎÁ§Æ®ÀÇ ¹üÀ§¿Í Á¤ÀÇ

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

  • ½ÃÀå ÀÎÁöµµ¿Í Á¦Ç° Á¤º¸
  • ºê·£µå ÀÎÁöµµ¿Í ·Î¿­Æ¼
  • ±¸ÀÔ °áÁ¤¿¡¼­ °í·ÁµÇ´Â ¿ä¼Ò
  • ±¸ÀÔ ºóµµ
  • ±¸ÀÔ ¸Åü

Á¦5Àå ¼¼°èÀÇ Å¬·Î·ÎÀÚÀÏ·¹³î ½ÃÀå Àü¸Á(2017³â-2031³â)

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×
  • Çüź°
    • ¾×ü
    • ºÐ¸»
  • ¿ëµµº°
    • º¸Á¸·á
    • ¹æºÎÁ¦
    • ¼Òµ¶Á¦
    • ±âŸ
  • ¼øµµº°
    • 98% ¹Ì¸¸
    • 99% ÀÌ»ó
  • ÃÖÁ¾ ¿ëµµº°
    • °¡Á¤
    • ÀÇ·á
    • ÆÛ½º³ÎÄÉ¾î ¹× È­Àåǰ
    • ±âŸ
  • Áö¿ªº°
    • ºÏ¹Ì
    • ³²¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå Á¡À¯À² : ±â¾÷º°(2023³â)

Á¦6Àå ¼¼°èÀÇ Å¬·Î·ÎÀÚÀÏ·¹³î ½ÃÀå Àü¸Á : Áö¿ªº°(2017³â-2031³â)

  • ºÏ¹Ì
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • Çüź°
    • ¿ëµµº°
    • ¼øµµº°
    • ÃÖÁ¾ ¿ëµµº°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½ºÆäÀÎ
    • ÅÍŰ
    • Æú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • È£ÁÖ
    • º£Æ®³²
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

Á¦7Àå °ø±ÞÃø ºÐ¼®

  • »ý»ê´É·Â : ±â¾÷º°
  • »ý»ê : ±â¾÷º°
  • ¿îÀü È¿À² : ±â¾÷º°
  • ÁÖ¿ä Ç÷£Æ® ¼ÒÀçÁö(ÃÖ´ë 25°³¼Ò)

Á¦8Àå ½ÃÀå ¸ÅÇÎ(2023³â)

  • Çüź°
  • ¿ëµµº°
  • ¼øµµº°
  • ÃÖÁ¾»ç¿ëÀÚº°
  • Áö¿ªº°

Á¦9Àå °Å½Ãȯ°æ°ú »ê¾÷ ±¸Á¶

  • ¼ö±Þ ºÐ¼®
  • ¼öÀÔ ¼öÃ⠺м®
  • ¹ë·ùüÀÎ ºÐ¼®
  • PESTEL ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦10Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ(°úÁ¦, ¼ºÀå ¾ïÁ¦¿äÀÎ)

Á¦11Àå ÁÖ¿ä ±â¾÷ »óȲ

  • ½ÃÀå ¸®´õ ÁÖ¿ä 5°³»çÀÇ °æÀï ¸ÅÆ®¸¯½º
  • ½ÃÀå ¸®´õ ÁÖ¿ä 5°³»çÀÇ ½ÃÀå ¸ÅÃ⠺м®(2023³â)
  • ÀμöÇÕº´(M&A)/ÇÕÀÛÅõÀÚ(ÇØ´çÇÏ´Â °æ¿ì)
  • SWOT ºÐ¼®(½ÃÀå ±â¾÷ 5°³»ç)
  • ƯÇ㠺м®(ÇØ´çÇÏ´Â °æ¿ì)

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå »ç·Ê ¿¬±¸

Á¦14Àå ÁÖ¿ä ±â¾÷ Àü¸Á

  • Lanxess AG
  • Reckitt Benckiser Group plc
  • Lonza Group
  • Stepan Company
  • Jiangsu Huanxin High-tech Materials Co., Ltd.
  • Nanjing Datang Chemical Co., Ltd.
  • SNEH CHEMICAL
  • Thomas Swan & Co. Ltd.
  • Evonik Industries AG
  • Hangzhou Jingyou Chemical Co., Ltd.

Á¦15Àå Àü·«Àû Ãßõ

Á¦16Àå ¹®ÀÇ ¹× ¸éÃ¥»çÇ×

LSH 24.04.24

Global chloroxylenol market is projected to witness a CAGR of 3.5% during the forecast period 2024-2031, growing from USD 151.3 million in 2023 to USD 199.23 million in 2031F. The market expansion is supported by increasing usage of personal care products and cosmetics, rising pharmaceutical applications, and others.

The increasing utilization of personal care products and cosmetics is boosting the global chloroxylenol market growth. The rising demand for personal care products and cosmetics can be attributed to increasing emphasis on physical appearance and growing investments by the leading cosmetic manufacturers towards marketing and promotional activities. The increasing influence of social media content creators is further encouraging consumers to invest in cosmetics and personal care products, supporting the market expansion as various personal care products and cosmetics use chloroxylenol. According to Cosmetics Europe- The Personal Care Association, in 2022, the European cosmetics market was valued at USD 95 billion (€88 billion) at Retail Sales Price (RSP). The rapid expansion of the cosmetic and personal care industry is bolstering the requirement for chloroxylenol as it is used as an anti-microbial agent in various cosmetic and personal care products.

The growing utilization of chloroxylenol in healthcare applications is another major driver increasing the global chloroxylenol market size. Due to its ability to act as an antimicrobial preservative, chloroxylenol is used in low concentrations as a pharmaceutical excipient in topical formulations, including ointments and creams. It is one of the common constituents of different proprietary disinfectants used for wound and skin disinfection. Regarding therapeutic applications, chloroxylenol has been investigated for treating infected root canals and acne vulgaris.

Increased Demand for Chloroxylenol from the Healthcare Sector

Chloroxylenol acts as an antimicrobial and treats abrasions, stings, bites, and cuts. It is employed as an antiseptic cleaner for hands. It is less active against Gram-negative bacteria and staphylococci and effective against Gram-positive bacteria. It is inactive against the Pseudomonas species. The activity against Gram-negative bacteria can be increased by adding a chelating agent, edetic acid. Chloroxylenol's boiling point is 246°C, and the melting point is 115.5°C. It is soluble in ether, fixed oils, terpenes, very slightly soluble in water, and freely soluble in ethanol. It also easily dissolves in alkali hydroxide solutions.

Chloroxylenol, with a molecular weight of 156.61 g/mol and a molecular formula of C8H9ClO, is used as a disinfectant and antiseptic agent for disinfecting surgical instruments and skin. For instance, as per the Lancet Commission on Global Surgery, in India, 3,646 surgeries are required in a year per 100,000 people. Of these, 13% require ophthalmological surgeries, 20% will be obstetrics and gynecological surgeries, and 26% will be general surgical procedures. Thus, the rising requirement for different surgical procedures for treating various chronic conditions is supplementing the market expansion by bolstering the product requirement.

Rising Requirement From the Pharmaceutical Sector Boosts Global Chloroxylenol Market Demand

Chloroxylenol is used in different pharmaceutical settings and hospitals as a disinfectant. It can be used as a pharmaceutical reference standard for determining the analyte in different pharmaceutical formulations with the help of fluorogenic derivatization before a high-performance liquid chromatography separation. Chloroxylenol is a broad spectrum, efficient, low-toxicity antibacterial with good chemical stability and a solubility of 0.03% in water. It is known to be bactericidal to a wide range of bacteria in low concentrations. The antimicrobial effect of the chemical compound occurs due to the disruption of cell membrane potentials. Thus, due to the above-mentioned benefits, the adoption of chloroxylenol in the pharmaceutical sector is increasing, thereby augmenting the global chloroxylenol market growth.

For instance, according to the recent data published by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical industry at the global level was valued at USD 1,256.8 billion in 2021 and reached USD 1,287.7 billion in 2022. In 2022, the global pharmaceutical industry registered a year-on-year growth rate of 2.5%. Moreover, according to the recent statistics published by IQVIA Inc., a biopharmaceutical company that has a presence across prominent regions such as North America, Asia-Pacific, and Europe, the medicines sector at the global level will reach USD 1.9 trillion by 2027. Henceforth, the rapid expansion of the pharmaceutical sector is boosting the demand for chloroxylenol, thereby fostering market growth.

Asia-Pacific is Expected to Witness Significant Growth in the Market

The market is expected to witness significant growth in Asia-Pacific over the forecast period. The rapid expansion of the population in the region, increasing awareness about the necessity of maintaining cleanliness and hygiene, and rising requirement by the hospitals and clinics in the region are expected to offer lucrative growth opportunities to the Asia Pacific chloroxylenol market. The rising requirement for caesarean sections in the region is another major factor supporting the market expansion as the product lowers the risk of surgical site infections. Due to the rising requirement for caesarean sections in different parts of the region, the demand for chloroxylenol is increasing significantly in the Asia-Pacific over the forecast period. For instance, as per the estimates of the World Health Organization (WHO) over the past few years a surge in caesarean section rate was witnessed. It is estimated that if the trend continues, the highest rates are expected to be in Eastern Asian Countries (63%), North Africa (48%), the Caribbean and the Latin America (54%), Australia and New Zealand (45%), Southern Europe (47%), and West Asia (50%).

Liquid Chloroxylenol to Account for Significant Global Chloroxylenol Market Share

The rising demand for liquid formulation can be attributed to their easy-to-use nature. The liquid formulation finds various applications in disinfectants, personal care products, and cleaners. It is used for antiseptic skin cleansing and gentle cleansing of wounds and disinfecting surgical instruments in hospitals. It acts as an effective antiseptic solution that aids in protecting against various germs and kills bacteria. Chloroxylenol has applications in dermatology surgery due to the ability of broad-spectrum antiseptics to reduce the risk of surgical site infections. Chloroxylenol is used for various procedures that enter the dermis or deeper. It is a halophenol that inactivates cellular enzymes and disrupts the microbial cell wall. Liquid formulations aid in disinfecting surface areas which are difficult to access. Thus, the various technical properties associated with liquid chloroxylenol are driving the market's growth.

Rising Requirement for Personal Care Products and Cosmetics Boosts Global Chloroxylenol Market Demand

Increasing utilization of hair care products due to rising concerns about physical appearance are expected to support the segment expansion. The chemical is used against a wide range of viruses, bacteria, and fungi. The product is effective against scalp issues in various demographics for individuals with textured hair. Due to different factors such as utilization of harsh hair products, dryness, and regular use of harmful styling techniques, these individuals become more susceptible to various scalp conditions including folliculitis, dandruff, and seborrheic dermatitis. Chloroxylenol has proven to be effective against such scalp conditions by acting against the causative fungi and bacteria. In a study conducted on African American subjects, shampoos that contained chloroxylenol effectively treated seborrheic dermatitis and dandruff as compared to the placebo shampoo. The Cosmetic Ingredient Review (CIR) Expert Panel has assessed the safety of chloroxylenol and deemed it safe for usage as a cosmetic ingredient.

Future Market Scenario (2024 - 2031F)

The rapid expansion of the pharmaceutical sector in the coming years will bolster the requirement for chloroxylenol as a pharmaceutical reference, disinfectant, and excipient, among other things.

The growing prevalence of various chronic health conditions, such as cancer, will support the market expansion as the treatment often involves surgeries, propelling the requirement for chloroxylenol for disinfecting surgical instruments. It is estimated that breast cancer accounts for approximately 12.5% of all cancer cases diagnosed across the globe in a year. In 2023, 297,790 cases of invasive breast cancer were diagnosed in the United States.

Due to the increasing incidences of skin infection in various regions across the globe, the demand for antibacterial soaps will increase, boosting the requirement for chloroxylenol.

Key Players Landscape and Outlook

Novel product launches by various market players and increasing collaborations, joint ventures, mergers, and acquisitions further support the market expansion. Such collaborations are expected to aid companies in expanding their customer base and effectively serve their customers.

Existing giants are investing in expanding their consumer base and entering new segments. For instance, in 2022 Dettol launched a multi-use antiseptic cream to create a niche for themselves in the wounds and cuts arena, building upon their existing antiseptic liquid. The product acts as a first level of treatment for tending to minor wounds and cuts to prevent the spread of infections on open wounds.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Chloroxylenol Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
  • 5.2.By Form
    • 5.2.1.Liquid
    • 5.2.2.Powder
  • 5.3.By Application
    • 5.3.1.Preservative
    • 5.3.2.Antiseptic
    • 5.3.3.Disinfectant
    • 5.3.4.Others
  • 5.4.By Purity
    • 5.4.1.Below 98%
    • 5.4.2.98.1% to 99%
    • 5.4.3.More than 99%
  • 5.5.By End-use
    • 5.5.1.Household
    • 5.5.2.Healthcare
    • 5.5.3.Personal Care & Cosmetic
    • 5.5.4.Others
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East & Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Chloroxylenol Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
    • 6.1.2.By Form
      • 6.1.2.1.Liquid
      • 6.1.2.2.Powder
    • 6.1.3.By Application
      • 6.1.3.1.Preservative
      • 6.1.3.2.Antiseptic
      • 6.1.3.3.Disinfectant
      • 6.1.3.4.Others
    • 6.1.4.By Purity
      • 6.1.4.1.Below 98%
      • 6.1.4.2.98.1% to 99%
      • 6.1.4.3.More than 99%
    • 6.1.5.By End-use
      • 6.1.5.1.Household
      • 6.1.5.2.Healthcare
      • 6.1.5.3.Personal Care & Cosmetic
      • 6.1.5.4.Others
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
      • 6.1.6.1.1.By Value
      • 6.1.6.2.By Form
      • 6.1.6.2.1.Liquid
      • 6.1.6.2.2.Powder
      • 6.1.6.3.By Application
      • 6.1.6.3.1.Preservative
      • 6.1.6.3.2.Antiseptic
      • 6.1.6.3.3.Disinfectant
      • 6.1.6.3.4.Others
      • 6.1.6.4.By Purity
      • 6.1.6.4.1.Below 98%
      • 6.1.6.4.2.98.1% to 99%
      • 6.1.6.4.3.More than 99%
      • 6.1.6.5.By End-use
      • 6.1.6.5.1.Household
      • 6.1.6.5.2.Healthcare
      • 6.1.6.5.3.Personal Care & Cosmetic
      • 6.1.6.5.4.Others
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Form
  • 8.2.By Application
  • 8.3.By Purity
  • 8.4.By End-user
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Value Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.Lanxess AG
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Reckitt Benckiser Group plc
  • 14.3.Lonza Group
  • 14.4.Stepan Company
  • 14.5.Jiangsu Huanxin High-tech Materials Co., Ltd.
  • 14.6.Nanjing Datang Chemical Co., Ltd.
  • 14.7.SNEH CHEMICAL
  • 14.8.Thomas Swan & Co. Ltd.
  • 14.9.Evonik Industries AG
  • 14.10.Hangzhou Jingyou Chemical Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦